RANBP2 and Parkinson disease: The marked increase in the steady state level of RANBP2 suggests a potential mechanism by which CA3 may enhance SUMOylation and nuclear transport, thereby stabilizing proteins implicated in neurodegenerative disorders such as Parkinson’s, Alzheimer’s, and Huntington’s diseases.